A Single-Dose, Open-Label, Randomized, 2-Period Crossover Study to Assess the Effect of Food Coadministration on the Pharmacokinetics of a Fixed Dose Combination Tablet of Canagliflozin (JNJ-28431754) and Metformin Extended Release in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 06 Aug 2014
Price : $35 *
At a glance
- Drugs Canagliflozin/metformin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Janssen
- 11 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Mar 2014 Status changed from not yet recruiting to active, no longer recruiting according to ClinicalTrials.gov record.
- 23 Jan 2014 New trial record